Citizens National Bank Trust Department’s Quest Diagnostics DGX Stock Holding History

Citizens National Bank Trust Department’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.7K	Hold	230	–	–	0.01%	269
2026 Q1	$45.1K	Hold	230	–	–	0.01%	265
2025 Q4	$39.9K	Hold	230	–	–	0.01%	267
2025 Q3	$43.8K	Hold	230	–	–	0.01%	265
2025 Q2	$41.3K	Hold	230	–	–	0.01%	254
2025 Q1	$38.9K	Hold	230	–	–	0.01%	257
2024 Q4	$34.7K	Hold	230	–	–	0.01%	246
2024 Q3	$35.7K	Hold	230	–	–	0.01%	240
2024 Q2	$31.5K	Hold	230	–	–	0.01%	243
2024 Q1	$30.6K	Buy	+230	New	+$29.8K	0.01%	244

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Citizens National Bank Trust Department's DGX Position: Q2 2026 in Review

Citizens National Bank Trust Department held its Quest Diagnostics (DGX) position steady in Q2 2026 at 230 shares worth $48.7K. The position accounts for 0.01% of the portfolio, ranked #269.

Citizens National Bank Trust Department first reported a position in DGX in Q1 2024 and has held it in 10 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Citizens National Bank Trust Department held 230 shares of Quest Diagnostics worth $48.7K as of Q2 2026.
Citizens National Bank Trust Department left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.01% of Citizens National Bank Trust Department's portfolio in Q2 2026, its #269 holding.
Citizens National Bank Trust Department first reported a position in Quest Diagnostics in Q1 2024 and has held it in 10 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.